Primary hyperparathyroidism influences the expression of inflammatory and metabolic genes in adipose tissue

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Christensen, Monika H E ^a,b   Dankel, Simon N ^a,b   Nordbø, Yngve ^b   Varhaug, Jan Erik ^a,b   Almås, Bjørg ^a,b   Lien, Ernst A ^a,b   Mellgren, Gunnar ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A DESATURASE; ACYL COENZYME A DESATURASE 1; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ARACHIDONATE 5 LIPOXYGENASE ACTIVATING PROTEIN; CALGRANULIN A; CALGRANULIN B; CARBONATE DEHYDRATASE IV; CD14 ANTIGEN; CD163 ANTIGEN; CD300 MOLECULE LIKE FAMILY MEMBER G; COLONY STIMULATING FACTOR 3 RECEPTOR; CXCL13 CHEMOKINE; FOLATE RECEPTOR 2; FRUCTOSE BISPHOSPHATE ALDOLASE; GELATINASE B; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED HIGH DENSITY LIPOPROTEIN BINDING PROTEIN 1; INTERLEUKIN 8; PHOSPHOPROTEIN PHOSPHATASE 1; PROTEIN; THROMBOSPONDIN 1; THROMBOSPONDIN 4; TRANSCRIPTION FACTOR; TYROSINE KINASE BINDING PROTEIN; UNCLASSIFIED DRUG; AUTACOID; PRIMER DNA;

ADIPOSE TISSUE; ADULT; AGED; ARTICLE; BINDING SITE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; IMMUNITY; INFLAMMATION; MALE; METABOLISM; NECK; NUCLEOTIDE SEQUENCE; PRIMARY HYPERPARATHYROIDISM; RISK FACTOR; RNA EXTRACTION; SUBCUTANEOUS FAT; THYROID DISEASE; UPREGULATION; CASE CONTROL STUDY; DNA MICROARRAY; ENERGY METABOLISM; GENETICS; POLYMERASE CHAIN REACTION;

ADIPOSE TISSUE; BASE SEQUENCE; CASE-CONTROL STUDIES; DNA PRIMERS; ENERGY METABOLISM; FEMALE; GENE EXPRESSION REGULATION; HUMANS; HYPERPARATHYROIDISM, PRIMARY; INFLAMMATION MEDIATORS; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION;

EID: 79959277578     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0020481     Document Type: Article

References (48)

1. Fraser WD, (2009) Hyperparathyroidism. Lancet 374: 145-158.
2. Wermers RA, Khosla S, Atkinson EJ, Achenbach SJ, Oberg AL, et al. (2006) Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993-2001: an update on the changing epidemiology of the disease. J Bone Miner Res 21: 171-177.
3. Jorde R, Bonaa KH, Sundsfjord J, (2000) Primary hyperparathyroidism detected in a health screening. The Tromso study. J Clin Epidemiol 53: 1164-1169.
4. Lundgren E, Rastad J, Thrufjell E, Akerstrom G, Ljunghall S, (1997) Population-based screening for primary hyperparathyroidism with serum calcium and parathyroid hormone values in menopausal women. Surgery 121: 287-294.
5. Rodgers SE, Lew JI, Solorzano CC, (2008) Primary hyperparathyroidism. Curr Opin Oncol 20: 52-58.
6. Christiansen P, Steiniche T, Brixen K, Hessov I, Melsen F, et al. (1999) Primary hyperparathyroidism: effect of parathyroidectomy on regional bone mineral density in Danish patients: a three-year follow-up study. Bone 25: 589-595.
7. Ogard CG, Engelmann MD, Kistorp C, Nielsen SL, Vestergaard H, (2005) Increased plasma N-terminal pro-B-type natriuretic peptide and markers of inflammation related to atherosclerosis in patients with primary hyperparathyroidism. Clin Endocrinol (Oxf) 63: 493-498.
8. Yu N, Donnan PT, Flynn RW, Murphy MJ, Smith D, et al. (2010) Increased mortality and morbidity in mild primary hyperparathyroid patients. The Parathyroid Epidemiology and Audit Research Study (PEARS). Clin Endocrinol (Oxf) 73: 30-34.
9. Rubin MR, Maurer MS, McMahon DJ, Bilezikian JP, Silverberg SJ, (2005) Arterial stiffness in mild primary hyperparathyroidism. J Clin Endocrinol Metab 90: 3326-3330.
10. Smith JC, Page MD, John R, Wheeler MH, Cockcroft JR, et al. (2000) Augmentation of central arterial pressure in mild primary hyperparathyroidism. J Clin Endocrinol Metab 85: 3515-3519.
11. Tassone F, Procopio M, Gianotti L, Visconti G, Pia A, et al. (2009) Insulin resistance is not coupled with defective insulin secretion in primary hyperparathyroidism. Diabet Med 26: 968-973.
12. Hagstrom E, Hellman P, Larsson TE, Ingelsson E, Berglund L, et al. (2009) Plasma parathyroid hormone and the risk of cardiovascular mortality in the community. Circulation 119: 2765-2771.
13. Packard RR, Libby P, (2008) Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clin Chem 54: 24-38.
14. Havel PJ, (2004) Update on adipocyte hormones: regulation of energy balance and carbohydrate/lipid metabolism. Diabetes 53 (Suppl 1): S143-151.
15. Cancello R, Henegar C, Viguerie N, Taleb S, Poitou C, et al. (2005) Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes 54: 2277-2286.
16. Dankel SN, Fadnes DJ, Stavrum AK, Stansberg C, Holdhus R, et al. (2010) Switch from stress response to homeobox transcription factors in adipose tissue after profound fat loss. PLoS One 5: e11033.
17. Dysvik B, Jonassen I, (2001) J-Express: exploring gene expression data using Java. Bioinformatics 17: 369-370.
18. Fellenberg K, Hauser NC, Brors B, Neutzner A, Hoheisel JD, et al. (2001) Correspondence analysis applied to microarray data. Proc Natl Acad Sci U S A 98: 10781-10786.
19. Bolstad BM, Irizarry RA, Astrand M, Speed TP, (2003) A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19: 185-193.
20. Tusher VG, Tibshirani R, Chu G, (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 98: 5116-5121.
21. Ho Sui SJ, Mortimer JR, Arenillas DJ, Brumm J, Walsh CJ, et al. (2005) oPOSSUM: identification of over-represented transcription factor binding sites in co-expressed genes. Nucleic Acids Res 33: 3154-3164.
22. Kern PA, Di Gregorio GB, Lu T, Rassouli N, Ranganathan G, (2003) Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression. Diabetes 52: 1779-1785.
23. Chudek J, Wiecek A, (2006) Adipose tissue, inflammation and endothelial dysfunction. Pharmacol Rep 58 (Suppl): 81-88.
24. Ryckman C, Vandal K, Rouleau P, Talbot M, Tessier PA, (2003) Proinflammatory activities of S100: proteins S100A8, S100A9, and S100A8/A9 induce neutrophil chemotaxis and adhesion. J Immunol 170: 3233-3242.
25. Gebhardt C, Nemeth J, Angel P, Hess J, (2006) S100A8 and S100A9 in inflammation and cancer. Biochem Pharmacol 72: 1622-1631.
26. Frosch M, Strey A, Vogl T, Wulffraat NM, Kuis W, et al. (2000) Myeloid-related proteins 8 and 14 are specifically secreted during interaction of phagocytes and activated endothelium and are useful markers for monitoring disease activity in pauciarticular-onset juvenile rheumatoid arthritis. Arthritis Rheum 43: 628-637.
27. Theroux P, Martel C, (2006) Complement activity and pharmacological inhibition in cardiovascular disease. Can J Cardiol 22 (Suppl B): 18B-24B.
28. Galis ZS, Khatri JJ, (2002) Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res 90: 251-262.
29. Tayebjee MH, Nadar S, Blann AD, Gareth Beevers D, MacFadyen RJ, et al. (2004) Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension and their relationship to cardiovascular risk and treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). Am J Hypertens 17: 764-769.
30. Blankenberg S, Rupprecht HJ, Poirier O, Bickel C, Smieja M, et al. (2003) Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease. Circulation 107: 1579-1585.
31. Galis ZS, Sukhova GK, Lark MW, Libby P, (1994) Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 94: 2493-2503.
32. Olson FJ, Schmidt C, Gummesson A, Sigurdardottir V, Hulthe J, et al. (2008) Circulating matrix metalloproteinase 9 levels in relation to sampling methods, femoral and carotid atherosclerosis. J Intern Med 263: 626-635.
33. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, et al. (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112: 1796-1808.
34. Boring L, Gosling J, Chensue SW, Kunkel SL, Farese RV Jr, et al. (1997) Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J Clin Invest 100: 2552-2561.
35. Puig-Kroger A, Sierra-Filardi E, Dominguez-Soto A, Samaniego R, Corcuera MT, et al. (2009) Folate receptor beta is expressed by tumor-associated macrophages and constitutes a marker for M2 anti-inflammatory/regulatory macrophages. Cancer Res 69: 9395-9403.
36. Gallant S, Gilkeson G, (2006) ETS transcription factors and regulation of immunity. Arch Immunol Ther Exp (Warsz) 54: 149-163.
37. Ray D, Bosselut R, Ghysdael J, Mattei MG, Tavitian A, et al. (1992) Characterization of Spi-B, a transcription factor related to the putative oncoprotein Spi-1/PU.1. Mol Cell Biol 12: 4297-4304.
38. Zakrzewska A, Cui C, Stockhammer OW, Benard EL, Spaink HP, et al. (2010) Macrophage-specific gene functions in Spi1-directed innate immunity. Blood 116: e1-11.
39. Wiesner P, Choi SH, Almazan F, Benner C, Huang W, et al. (2010) Low doses of lipopolysaccharide and minimally oxidized low-density lipoprotein cooperatively activate macrophages via nuclear factor kappa B and activator protein-1: possible mechanism for acceleration of atherosclerosis by subclinical endotoxemia. Circ Res 107: 56-65.
40. Oberkofler H, Fukushima N, Esterbauer H, Krempler F, Patsch W, (2002) Sterol regulatory element binding proteins: relationship of adipose tissue gene expression with obesity in humans. Biochim Biophys Acta 1575: 75-81.
41. Ntambi JM, Miyazaki M, Stoehr JP, Lan H, Kendziorski CM, et al. (2002) Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity. Proc Natl Acad Sci U S A 99: 11482-11486.
42. Brown JM, Chung S, Sawyer JK, Degirolamo C, Alger HM, et al. (2008) Inhibition of stearoyl-coenzyme A desaturase 1 dissociates insulin resistance and obesity from atherosclerosis. Circulation 118: 1467-1475.
43. Riserus U, Tan GD, Fielding BA, Neville MJ, Currie J, et al. (2005) Rosiglitazone increases indexes of stearoyl-CoA desaturase activity in humans: link to insulin sensitization and the role of dominant-negative mutation in peroxisome proliferator-activated receptor-gamma. Diabetes 54: 1379-1384.
44. Mayas MD, Ortega FJ, Macias-Gonzalez M, Bernal R, Gomez-Huelgas R, et al. (2010) Inverse relation between FASN expression in human adipose tissue and the insulin resistance level. Nutr Metab (Lond) 7: 3.
45. Chang E, Donkin SS, Teegarden D, (2009) Parathyroid hormone suppresses insulin signaling in adipocytes. Mol Cell Endocrinol 307: 77-82.
46. Raggatt LJ, Qin L, Tamasi J, Jefcoat SC Jr, Shimizu E, et al. (2008) Interleukin-18 is regulated by parathyroid hormone and is required for its bone anabolic actions. J Biol Chem 283: 6790-6798.
47. McClelland P, Onyia JE, Miles RR, Tu Y, Liang J, et al. (1998) Intermittent administration of parathyroid hormone (1-34) stimulates matrix metalloproteinase-9 (MMP-9) expression in rat long bone. J Cell Biochem 70: 391-401.
48. Nakajima K, Okazaki T, Okamoto T, Kimura H, Takano K, et al. (2010) Genes up- or down-regulated by high calcium medium in parathyroid tissue explants from patients with primary hyperparathyroidism. Endocr J 57: 153-159.